| 11:30 | DEBATE 1 --- Current treatment options in CSCR in timesof shortage of Visudyne | |||
| 11:31 | ... Introduction Debate 1 | DIRVEN W | ||
| 11:32 | ... Audience Vote 1 - Debate 1 | |||
| 11:33 | ... Stick to the gold standard half-dose PDT treatment with Visudyne | KOZYREFF A | ||
| 11:43 | ... Try and look for alternative treatments, as Visudyne is hardly available | GOETHALS S | ||
| 11:53 | ... Moderatored Discussions between the Speakers Debate 1 | |||
| 11:59 | ... Audience Vote 2 - Debate 1 | |||
| 12:00 | DEBATE 2 --- Switching to steroids in DME-treatment | |||
| 12:01 | ... Introduction Debate 2 | DIRVEN W | ||
| 12:02 | ... Audience Vote 1 - Debate 2 | |||
| 12:03 | ... Steroids are the best choice we have in poor responders to anti-VEGF | RASQUIN F | ||
| 12:13 | ... Steroids are not the holy grail, there are better options on the way | LOCHT B | ||
| 12:23 | ... Moderatored Discussions between the Speakers Debate 2 | |||
| 12:29 | ... Audience Vote 2 - Debate 2 | |||
| 12:30 | DEBATE 3 --- The best approach for treating disturbing vitreous floaters | |||
| 12:31 | ... Introduction Debate 3 | DIRVEN W | ||
| 12:32 | ... Audience Vote 1 - Debate 3 | |||
| 12:33 | ... Laser treatment | TASSIGNON M | ||
| 12:43 | ... Vitrectomy | DEPLA J | ||
| 12:53 | ... Moderatored Discussions between the Speakers Debate 2 | |||
| 12:59 | ... Audience Vote 2 - Debate 3 | |||
| 13:00 | End of Session | |||